Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 7/20 | 0.39 |
| ▸ | NAMPT | P43490 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9968585 | 0.84 | PKM (0.50) | CYP19A1SLC6A2SLC6A4SLC6A3NAMPT | |
| SCHEMBL9968024 | 0.83 | SLC6A2 (0.45) | CYP19A1SLC6A2SLC6A4SLC6A3NAMPT | |
| SCHEMBL15609570 | 0.82 | MAPT (0.58) | — | |
| SCHEMBL9968023 | 0.81 | SLC6A2 (0.41) | CYP19A1SLC6A2SLC6A4SLC6A3NAMPT | |
| SCHEMBL9968581 | 0.81 | KDM4E (0.43) | CYP19A1SLC6A2SLC6A4SLC6A3NAMPT | |
| SCHEMBL9968569 | 0.79 | MAPK1 (0.44) | SLC6A2SLC6A4SLC6A3NAMPT | |
| SCHEMBL9941378 | 0.76 | TSHR (0.58) | — | |
| SCHEMBL6677829 | 0.72 | SLC22A12 (0.50) | SLC22A12 | |
| SCHEMBL26536708 | 0.69 | ALDH1A1 (0.52) | — | |
| SCHEMBL15682729 | 0.68 | MEP1B (0.55) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012082862-A2 | ANDROGEN RECEPTOR INHIBITORS AND METHODS OF USE THEREOF | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2012-06-21 | — | — | WO | disclosed |